Overall rank by patents
#36,119
Across all tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 8 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA).
The verdict
Kadri holds 7 US patents across 8 technology areas, rank #36,119 of 50,000 tracked assignees.
Kadri Medical Ltd. has been granted 7 US utility patents between 2021 and 2025, placing Kadri Medical Ltd. at rank #36,119 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 6.4 claims per patent with primary concentration in G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA). As a Foreign Corporation, Kadri Medical Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Kadri sits between Kyoto Semiconductor Co., Ltd. (7 patents, rank #36,115) and Kandji, Inc. (7 patents, rank #36,123) - the closest US assignees by grant volume. The composite Innovation Score of 34.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 7 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Kadri Medical Ltd.'s 6.4 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 8 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Kadri Medical Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
KYOTO SEMICONDUCTOR CO., LTD.
7 patents
KYUSYU NANOTEC OPTICS CO., LTD.
7 patents
KYYNEL OY
7 patents
Kabushiki Kaisha Tokyo Kikai Seisakusho
7 patents
Kaiser Foundation Hospitals
7 patents
Kaivac, Inc.
7 patents
Kalypto Medical, Inc.
7 patents
Kandji, Inc.
7 patents
Kadri Medical Ltd.
7 patents
What this shows Kadri holds 7 patents at rank #36,119, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #36,119 in granted patent volume.
Other assignees with the most granted patents in Kadri's primary technology class.
Kadri's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
34 Top 53% higher than 47% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 2 | 28.6% |
| 2022 | 2 | 28.6% |
| 2024 | 2 | 28.6% |
| 2025 | 1 | 14.3% |
Top 8 of 8 technology areas
Overall rank by patents
#36,119
Across all tracked assignees
34.4 out of 100
How to use this portfolio
Kadri's 7 grants land it in the top 53% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.